News
Case builds for Biogen, Stoke's Dravet syndrome drug
Hopes have risen for a new treatment for severe childhood epilepsy Dravet syndrome, on the back of new data for Biogen and Stoke's zorevunersen.
News
AbbVie cuts $1.9bn+ deal with IGI for trispecific antibody
AbbVie has signed another deal in its effort to build an industry-leading position in multispecific antibodies for blood cancers.
News
Cash injection will help Varda make drugs in space
A new US startup, called Varda Space Industries, has raised $187 million in financing for a bold plan to manufacture medicines in orbit.
News
Just how radical is the FDA's complete response letter move?
The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.
R&D
When is the superbug message going to bite?
As existing antibiotics become less effective, we edge closer to a future where routine infections & minor injuries could once again become high risk.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
